Browsing "Medicine publications" by Author Krum, H.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 10 to 25 of 25 < previous 
PreviewIssue DateTitleAuthor(s)
2013Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classesCampbell, D.; McGrady, M.; Prior, D.; Coller, J.; Boffa, U.; Shiel, L.; Liew, D.; Wolfe, R.; Stewart, S.; Reid, C.; Krum, H.
2013N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: Results of the SCReening Evaluation of the Evolution of New-Heart Failure Study (SCREEN-HF)McGrady, M.; Reid, C.M.; Shiel, L.; Wolfe, R.; Boffa, U.; Liew, D.; Campbell, D.J.; Prior, D.; Krum, H.
2013NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: Results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF)McGrady, M.; Reid, C.; Shiel, L.; Wolfe, R.; Boffa, U.; Liew, D.; Campbell, D.; Prior, D.; Stewart, S.; Krum, H.
2013Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the which? trialWhitty, J.; Stewart, S.; Carrington, M.; Calderone, A.; Marwick, T.; Horowitz, J.; Krum, H.; Davidson, P.; Macdonald, P.; Reid, C.; Scuffham, P.; Fielding, R.
2019Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohortCampbell, D.J.; Gong, F.F.; Jelinek, M.V.; Castro, J.M.; Coller, J.M.; McGrady, M.; Boffa, U.; Shiel, L.; Wang, B.H.; Liew, D.; Wolfe, R.; Stewart, S.; Owen, A.J.; Krum, H.; Reid, C.M.; Prior, D.L.
2014Prolonged impact of home versus clinic-based management of chronic heart failure: extended follow-up of a pragmatic, multicentre randomized trial cohortStewart, S.; Carrington, M.; Horowitz, J.; Marwick, T.; Newton, P.; Davidson, P.; Macdonald, P.; Thompson, D.; Chan, Y.; Krum, H.; Reid, C.; Scuffham, P.
2012Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertensionMahfoud, F.; Cremers, B.; Janker, J.; Link, B.; Vonend, O.; Ukena, C.; Linz, D.; Schmieder, R.; Rump, L.; Kindermann, I.; Sobotka, P.; Krum, H.; Scheller, B.; Schlaich, M.; Laufs, U.; Böhm, M.
2018Risk factor management in a contemporary Australian population at increased cardiovascular disease riskCampbell, D.J.; Coller, J.M.; Gong, F.F.; McGrady, M.; Prior, D.L.; Boffa, U.; Shiel, L.; Liew, D.; Wolfe, R.; Owen, A.J.; Krum, H.; Reid, C.M.
2022Risk factors for asymptomatic echocardiographic abnormalities that predict symptomatic heart failureColler, J.M.; Gong, F.F.; McGrady, M.; Shiel, L.; Liew, D.; Stewart, S.; Owen, A.J.; Krum, H.; Reid, C.M.; Prior, D.L.; Campbell, D.J.
2018Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohortGong, F.F.; Jelinek, M.V.; Castro, J.M.; Coller, J.M.; McGrady, M.; Boffa, U.; Shiel, L.; Liew, D.; Wolfe, R.; Stewart, S.; Owen, A.J.; Krum, H.; Reid, C.M.; Prior, D.L.; Campbell, D.J.
2007Rural and urban differentials in primary care management of chronic heart failure: new data from the CASE studyRobyn, S.; Eckert, K.; Stewart, S.; Phillips, S.; Yallop, J.; Tonkin, A.; Krum, H.
2013Telephone support to rural and remote patients with heart failure: the Chronic Heart Failure Assessment by Telephone (CHAT) studyKrum, H.; Forbes, A.; Yallop, J.; Driscoll, A.; Croucher, J.; Chan, B.; Clark, R.; Davidson, P.; Huynh, L.; Kasper, E.K.; Hunt, D.; Egan, H.; Stewart, S.; Piterman, L.; Tonkin, A.
2011The WHICH? trial: rationale and design of a pragmatic randomized, multicentre comparison of home- vs. clinic-based management of chronic heart failure patientsStewart, S.; Carrington, M.; Marwick, T.; Davidson, P.; Macdonald, P.; Horowitz, J.; Krum, H.; Newton, P.; Reid, C.; Scuffham, P.
2016The β-blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trialRoberts, M.A.; Pilmore, H.L.; Ierino, F.L.; Badve, S.V.; Cass, A.; Garg, A.X.; Isbel, N.M.; Krum, H.; Pascoe, E.M.; Perkovic, V.; Scaria, A.; Tonkin, A.M.; Vergara, L.A.; Hawley, C.M.; Levin, A.; Hare, D.; Martin, A.; Wheeler, D.C.; Fulcher, G.; Brown, H.; et al.
2011Therapeutic Effects of Human STRO-3-Selected Mesenchymal Precursor Cells and their Soluble Factors in Experimental Myocardial IschemiaSee, F.; Seki, T.; Psaltis, P.; Sondermeijer, H.; Gronthos, S.; Zannettino, A.; Govaert, K.; Schuster, M.; Kurlansky, P.; Kelly, D.; Krum, H.; Itescu, S.
2019Tranexamic acid in coronary artery surgery: one-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trialMyles, P.S.; Smith, J.A.; Kasza, J.; Silbert, B.; Jayarajah, M.; Painter, T.; Cooper, D.J.; Marasco, S.; McNeil, J.; Bussières, J.S.; McGuinness, S.; Byrne, K.; Chan, M.T.V.; Landoni, G.; Wallace, S.; Forbes, A.; Esmore, D.; Krum, H.; Tonkin, A.; Buxton, B.; et al.